12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Altamira Therapeutics (NASDAQ:CYTO) stock increased by 222.5% to $0.32 during Friday’s regular session. As of 12:31 EST,…
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday.
The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500 also fell, dropping, 0.80% to 4,347.67.
Why Is Cancer Firm Ikena Oncology Stock Trading Lower Today?
Ikena Oncology Inc (NASDAQ: IKNA) shared initial data from twenty-six patients treated in the ongoing dose escalation portion of the
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 156.6% to $0.58 during Thursday’s regular session. Trading volume for…
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday.
The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53. The S&P 500 also rose, gaining, 0.16% to 4,389.61.
Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform
Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.
Benzinga’s Top Ratings Upgrades, Downgrades For September 22, 2023
Upgrades For Agile Therapeutics Inc (NASDAQ:AGRX), Maxim Group upgraded the previous rating of Hold to Buy. For the…
Analyst Ratings for Ikena Oncology
Within the last quarter, Ikena Oncology (NASDAQ:IKNA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Ikena Oncology Raises $40M Via Secondary Stock Offering Of 6.11M Shares At $6.55 Per Share
Ikena Oncology, Inc. (NASDAQ:IKNA, ", Ikena", , ", Company", )))), a targeted oncology company forging new territory in patient-directed cancer treatment, announced today the pricing of an